Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dr. Reddy’s Petition Seeks Swift Review For Certain Secondary ANDA Filers

Executive Summary

Dr. Reddy’s has come up with a new strategy for some secondary ANDA applicants to get their products on the market quicker.

You may also be interested in...

ANDA User Fee Negotiations: A Big-Firm Coalition Tackles The Big Backlog

FDA has long negotiated its brand user fee program with two distinct but closely aligned industry groups: the Pharmaceutical Research and Manufacturers of America and the Biotechnology Industry Organization. Now the agency will be using those same discussion techniques as it develops the generic drug user fee program.

FDA Reverses Stance On Bioequivalence Standards For Mesalamine

FDA believes that comparative pharmacokinetic studies, instead of comparative clinical endpoint studies, are best for determining bioequivalence of extended- or delayed-release mesalamine products - a reversal of its previous position

Citizen Petitions Are Not Proper Way To Initiate FDA Enforcement Actions, Agency Says

FDA rejects a 2002 petition by Paddock Laboratories asking the agency to take action against manufacturers of ammonium lactate cream and lotion.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts